126 related articles for article (PubMed ID: 32442056)
1. Quantification of mucosal EEC in jejunum. A comparative study of IBS patients and healthy controls.
Mohammadian G; Dlugosz A; Shetye J; Lindberg G
Scand J Gastroenterol; 2020 May; 55(5):543-548. PubMed ID: 32442056
[No Abstract] [Full Text] [Related]
2. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.
Wang SH; Dong L; Luo JY; Gong J; Li L; Lu XL; Han SP
World J Gastroenterol; 2007 Dec; 13(45):6041-7. PubMed ID: 18023097
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.
Dlugosz A; Törnblom H; Mohammadian G; Morgan G; Veress B; Edvinsson B; Sandström G; Lindberg G
BMC Gastroenterol; 2010 Feb; 10():19. PubMed ID: 20158890
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH
BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
[TBL] [Abstract][Full Text] [Related]
5. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
6. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
Scand J Gastroenterol; 2017; 52(6-7):691-697. PubMed ID: 28346031
[TBL] [Abstract][Full Text] [Related]
8. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
[TBL] [Abstract][Full Text] [Related]
9. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
Mazzawi T; El-Salhy M
Int J Mol Med; 2016 May; 37(5):1247-53. PubMed ID: 26987104
[TBL] [Abstract][Full Text] [Related]
10. Infection of human enteroendocrine cells with Chlamydia trachomatis: a possible model for pathogenesis in irritable bowel syndrome.
Dlugosz A; Zakikhany K; Muschiol S; Hultenby K; Lindberg G
Neurogastroenterol Motil; 2011 Oct; 23(10):928-34. PubMed ID: 21883697
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome.
Dlugosz A; Zakikhany K; Acevedo N; D'Amato M; Lindberg G
Biomed Res Int; 2017; 2017():9624702. PubMed ID: 28246611
[TBL] [Abstract][Full Text] [Related]
12. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.
El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
Scand J Gastroenterol; 2017 Dec; 52(12):1331-1339. PubMed ID: 28853300
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Guilarte M; Vicario M; Martínez C; de Torres I; Lobo B; Pigrau M; González-Castro A; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Antolín M; Saperas E; Azpiroz F; Santos J; Alonso-Cotoner C
Am J Gastroenterol; 2020 Dec; 115(12):2047-2059. PubMed ID: 32740086
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
El-Salhy M; Mazzawi T; Gundersen D; Hausken T
Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
[TBL] [Abstract][Full Text] [Related]
15. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
[TBL] [Abstract][Full Text] [Related]
16. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
[TBL] [Abstract][Full Text] [Related]
17. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.
Dothel G; Barbaro MR; Boudin H; Vasina V; Cremon C; Gargano L; Bellacosa L; De Giorgio R; Le Berre-Scoul C; Aubert P; Neunlist M; De Ponti F; Stanghellini V; Barbara G
Gastroenterology; 2015 May; 148(5):1002-1011.e4. PubMed ID: 25655556
[TBL] [Abstract][Full Text] [Related]
18. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
19. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
